Alyeska Investment Group
ONCR

Alyeska Investment Group’s Oncorus, Inc. ONCR Stock Holding History

Alyeska Investment Group’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-77,148
Closed -$1.06M – 847
2021
Q2 		$1.06M Hold
77,148
– – 0.01% 577
2021
Q1 		$1.07M Buy
+77,148
New +$1.6M 0.01% 552

Other funds holding ONCR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group's ONCR Position: Q3 2021 in Review

Alyeska Investment Group sold out of Oncorus, Inc. (ONCR) in Q3 2021, closing a stake of 77,148 shares — an estimated $1.06M sold.

Alyeska Investment Group first reported a position in ONCR in Q1 2021 and held it in 2 quarters. The position peaked at $1.07M in Q1 2021. 48 funds tracked by Wall St. Rank hold ONCR as of Q3 2021.

  • Alyeska Investment Group reported no remaining Oncorus, Inc. position as of Q3 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 77,148 Oncorus, Inc. shares in Q3 2021, an estimated $1.06M.
  • Alyeska Investment Group first reported a position in Oncorus, Inc. in Q1 2021 and held it in 2 quarters.
  • Alyeska Investment Group's Oncorus, Inc. position peaked at $1.07M in Q1 2021.
  • 48 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q3 2021.

Based on Alyeska Investment Group's 13F filing for Q3 2021, filed 15 Nov 2021.